乳腺癌节拍化疗.ppt

《乳腺癌节拍化疗.ppt》由会员分享，可在线阅读，更多相关《乳腺癌节拍化疗.ppt（28页珍藏版）》请在三一办公上搜索。

1、乳腺癌节拍化疗,节拍化疗 vs 传统化疗,节拍化疗：小剂量化疗药、频繁、规律给药传统化疗：最大耐受剂量、每3周间隔给药,传统化疗,节拍化疗,Metronomic Chemotherapy-a Multi-targeted Chemotherapy,Number of published papers over the years,Number of published papers according to country/region,节拍化疗在乳腺癌中的应用,晚期乳腺癌：姑息化疗，尤其是老人、多线治疗患者早期乳腺癌：辅助化疗/新辅助化疗,Metronomic Drug,Cyclophosp

2、hamideMethotrexateFluorouracil:FT207/UFT/CapecitabineEtoposideVinorelbineTemozolomideTaxanespegylated liposomal doxorubicinIrinotecanCisplatin,口服便宜耐受好,Metronomic Schedule,Pure metronomic chemotherapyMetronomic chemotherapy+Hormonal therapyMetronomic chemotherapy+Targeted therapyMetronomic chemothera

3、py+Tmmunologic agentsMetronomic chemotherapy+Drug repositioning,Ongoing Pure metronomic studies,Metronomic Chemotherapy and Hormonal Therapy,SERD:Tamoxifen/ToremifeneAromotase inhibitorFulvestrant,1477 post menopausal HR positive BC patients,激素受体阳性的绝经后乳腺癌患者，化疗与他莫西芬同时使用差于序贯使用,绝境前女性化疗可否与他莫昔芬联合使用？其他内分泌

4、药物可否与化疗同时使用？芳香化酶抑制剂？氟维司群？,Randomized Phase II Trial of Letrozole and Letrozole Plus Low-Dose Metronomic Oral Cyclophosphamide As Primary Systemic Treatment in Elderly Breast Cancer Patients,CR+PR=ORR,40.3%+31.6%=71.9%,43.8%+43.8%=87.6%,J Clin Oncol,2006,Other Trials,Ongoing Trials,Metronomic Chemoth

5、erapy and Targeted Therapy,Ongoing Trials,Metronomic Chemotherapy and Immunologic Agents,Metronomic Chemotherapy and Drug Repositioning,Other Repositioning Drugs,Metformin（二甲双胍）propranolol（普荼洛尔）,节拍化疗存在的问题,传统MTD的化疗模式“根深蒂固”节拍化疗概念模糊，用药剂量、频次、间隔不清晰经验用药，缺少期随机对照研究的证据；缺少可靠的疗效预测指标,PK/PD Driven Metronomics,Bi

6、omarker of Metronomic Chemotherapy,Plasma VEGF and VEGF gene polymorphismsCirculating endothelial progenitor cells(CEP)Thrombospondin-1(TSP-1)THBS1212(endogenous angiogenesis inhibitor)Macrocytosis(mean corpuscular volume 100 fl)HIF1 Immune factors:TREG cells,口服长春瑞滨节拍化疗对比常规化疗的疗效和安全性研究,生物标志物的检测：血管生成指标、免疫指标血药浓度监测,谢谢!,